Directors dealings: NAIT boosts stake in EKF Diagnostics to 14.1%
10th Jun 2016 14:11
(ShareCast News) - Harwood Capital, acting as investment manager on behalf of North Atlantic Smaller Companies Investment Trust PLC, picked up another large batch of shares in EKF Diagnostics. Christoper Mills, who was named to the post of non-executive chairman at the global point-of-care medical d
Read moreEKF Diagnostics non-exec resigns as new chairman joins
11th Apr 2016 12:20
(ShareCast News) - Ron Zwanziger has resigned as non-executive director of EKF Diagnostics with immediate effect. The AIM-listed point-of-care business confirmed the news in a statement on Monday. Last week, EKF appointed Christopher Mills as non-executive chairman with immediate effect. Mills is c
Read moreEKF Diagnostics appoints chairman
8th Apr 2016 16:00
(ShareCast News) - The AIM-listed point-of-care business EKF Diagnostics Holdings has appointed Christopher Mills as non-executive chairman with immediate effect. The incoming chairman is chief executive and the sole shareholder of Harwood Capital Management Limited and founder of JO Hambro. Mills
Read moreEKF Diagnostics kitchen-sinking will drive break-even 'by April'
3rd Feb 2016 13:04
(ShareCast News) - Shares in EKF Diagnostics bounced off their all-time low thanks to a trading update that reiterated full-year profit guidance and emphasised its total focus on point-of-care. After a dark end to 2015, in which one director died and the company announced a significant profit warnin
Read moreEKF admits defeat with Selah acquisition
23rd Dec 2015 14:27
(ShareCast News) - EKF Diagnostics Holdings all but admitted defeat in its experiment with personalised medicine on Wednesday, as it let go of its wholly-owned subsidiary Selah back to the founders. The AIM-listed medical diagnostic business confirmed it had reached agreement to sell the US-based de
Read moreEKF Diagnostics boosted by kidney disease study results
9th Nov 2015 12:03
(ShareCast News) - A clinical study part-funded by EKF Diagnostics has provided encouraging data about its soluble biomarker in predicting the progression of diabetic kidney disease, which could lead to recruitment of more suitable patients for further trials. The study, which was co-authored by EKF
Read moreEKF Diagnostics receives two offers for its point-of-care division
23rd Aug 2015 11:13
(ShareCast News) - EKF Diagnostics, which was recently pressured by its major shareholders into putting its point-of-care business up for sale, has reportedly received offers from two unidentified bidders. The larger of the two bids is believed to have a value of £76.4m, according to City sources ci
Read moreEKF Diagnostics agrees non-binding sale of assets
18th Aug 2015 12:24
(ShareCast News) - EKF Diagnostics Holdings has agreed a non-binding deal to sell its point-of-care business for $110m (£70m) and assured investors that it expects to hit its full year target despite declining first-half profits. Under pressure from shareholders eager to realise some of the value al
Read moreEKF Diagnostics tanks as it swings to annual loss on exceptional costs
16th Mar 2015 09:24
Shares in medical diagnostic equipment producer EKF Diagnostic tanked on Monday as the group swung to an annual pre-tax loss in 2014 on exceptional costs. The London-listed company said it swung from a pre-tax profit of £607,000 to a pre-tax loss of £4m, as administration expenses increased on the b
Read moreEKF Diagnostics warns on profit on currency hit and lower revenue from buys
17th Dec 2014 09:12
Medical group EKF Diagnostics warned on annual profits after taking a currency hit and saying revenue from newly acquired companies was likely to be lower than expected. EKF said acquisitions during the year of Diaspect, Selah Genomics and STI were set to contribute at least £6.1m to overall revenue
Read moreTuesday broker round-up UPDATE
30th Sep 2014 09:50
Aberdeen: Goldman Sachs ups target price from 540p to 560pp retaining a buy recommendation. African Barrick Gold: Deutsche Bank moves target price from 270p to 280p and reiterates a hold recommendation. Investec lowers target price from 260p to 258p, while upgrading to buy. African Minerals: Invest
Read moreEKF Diagnostics takes big step in cancer detection
2nd Jun 2014 08:38
Medical group EKF Diagnostics says a partnership in which it is involved has made a major step towards detecting cancer in blood. EKF said first results from its collaboration with German group Gilupi had successfully shown detection of gene mutations from as few as three or less isolated cells and
Read moreThursday broker round-up UPDATE
22nd May 2014 08:34
ASOS: Goldman Sachs reduces target price from 7300p to 6250p, while upgrading to buy. BTG: N+1 Singer shaves target price from 488p to 486p retaining a sell recommendation. EKF Diagnostics: FinnCap initiates with a target price of 38p and a buy recommendation. Exova Group: Credit Suisse starts wi
Read moreWednesday broker round-up UPDATE
7th May 2014 08:35
Balfour Beatty: Jefferies reduces target price from 403p to 233p downgrading to hold. Deutsche Bank cuts target price from 280p to 250p and leaves its hold recommendation unchanged. Numis reduces target price to 260p and retains an add rating. Barclays: Deutsche Bank lowers target price from 320p t
Read moreCarnival Chairman reduces stake by around a quarter
26th Mar 2014 15:54
Micky Arison, the long-standing Chairman of cruise line operator Carnival Corp., docked a batch of shares earlier this week ahead of its better-than-expected first quarter trading update. Arison offloaded 525,348 at $40.09 each, reducing his stake to 104.52m shares. The group on Tuesday reported
Read more